Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Live Nation Entertainment, Inc. (LYV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Live Nation Entertainment, Inc. — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B), while Live Nation Entertainment, Inc. trades at $169.98 (market cap $39.33B). The key difference: Live Nation Entertainment, Inc. is far larger — about 4.4× Kymera Therapeutics Inc. Common Stock's market cap, and Live Nation Entertainment, Inc. is more actively traded (1,350,559 versus 1,028,790). Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Live Nation Entertainment, Inc. for 72 Days on average.
| KYMR | LYV | |
|---|---|---|
Market Cap | $8.88B | $39.33B |
Volume | 1,028,790 | 1,350,559 |
Sector | Health | Media |
52-Week High | $127.31 | $188.46 |
52-Week Low | $55.80 | $125.61 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $8.27B | $41.54B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
LYV trades at $171.32, up 0.99% today, with a neutral technical signal and strong analyst support. The stock shows robust revenue growth, reaching $25.20B in 2025, but profitability remains thin with a net margin of 0.51% and a high P/E of 117.49. Recent news highlights strong fan demand and strategic partnerships, such as the Salesforce integration announced on September 16, 2026, while legal and debt risks persist.
The outlook is cautiously optimistic, driven by sustained demand for live events and a consensus price target of $208.64, but investors face risks from high valuation, regulatory scrutiny, and volatile earnings, with Q3 2026 results critical for confirming growth momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Live Nation Entertainment, Inc.
Live Nation is the largest live entertainment firm in the world with over 570 million fans served in 44 countries in 2018 by the company's concert and ticketing platforms. Via either owning, operating, or holding exclusive booking rights, Live Nation controls over 235 venues including the House of Blues, the Hollywood Palladium, and Spark Arena in New Zealand. Live Nation also owns one of the largest ticketing services, Ticketmaster, which sold over 480 million tickets for over 12,000 clients in 2018. The firm's artist management agencies have over 400 clients. This large live entertainment footprint helped Live Nation become one of the largest advertising and sponsorship platforms aimed at music fans. Liberty Media owns 33% of Live Nation, held under its SiriusXM tracking stock.
Read more on LYV →
